Correlation Between ELYM Old and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both ELYM Old and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ELYM Old and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ELYM Old and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on ELYM Old and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ELYM Old with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ELYM Old and Acrivon Therapeutics,.
Diversification Opportunities for ELYM Old and Acrivon Therapeutics,
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ELYM and Acrivon is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding ELYM Old and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and ELYM Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ELYM Old are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of ELYM Old i.e., ELYM Old and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between ELYM Old and Acrivon Therapeutics,
Given the investment horizon of 90 days ELYM Old is expected to generate 1.01 times more return on investment than Acrivon Therapeutics,. However, ELYM Old is 1.01 times more volatile than Acrivon Therapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.0 per unit of risk. If you would invest 362.00 in ELYM Old on October 16, 2024 and sell it today you would lose (53.00) from holding ELYM Old or give up 14.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 94.95% |
| Values | Daily Returns |
ELYM Old vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| ELYM Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Acrivon Therapeutics, |
ELYM Old and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ELYM Old and Acrivon Therapeutics,
The main advantage of trading using opposite ELYM Old and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ELYM Old position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.The idea behind ELYM Old and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |